Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AN2690 (Tavaborole) in Onychomycosis
NCT01270971Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tavaborole in onychomycosis, sponsored by Pfizer. Started Dec 2010; status: completed.
02
Drugs
tavaborole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT01270971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270971.